Difference between revisions of "Plicamycin (Mithracin)"
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>") |
m |
||
Line 11: | Line 11: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
+ | |||
+ | [[Category:Drug index]] | ||
+ | [[Category:Chemotherapy]] | ||
+ | [[Category:Irritant chemotherapy]] | ||
+ | [[Category:Vesicant chemotherapy]] | ||
+ | [[Category:DNA synthesis inhibitors]] | ||
+ | |||
+ | [[Category:Drugs FDA approved in 1970]] |
Revision as of 15:46, 9 November 2014
General information
Class/mechanism: Antibiotic oncologic, intercalates DNA base pairs, and inhibits DNA and RNA synthesis. Has been used for hypercalcemia; lowers serum calcium levels independent of cytotoxic activity by blocking parathyroid hormone action on osteoclasts.[1][2]
Route: IV
Extravasation: irritant/vesicant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]